(See CLINICAL PHARMACOLOGY, Clinical Studies.)
The efficacy of PRILOSEC used for longer than 8 weeks in these patients has not been established. In the rare instance of a patient not responding to 8 weeks of treatment, it may be helpful to give up to an additional 4 weeks of treatment. If there is recurrence of erosive esophagitis or GERD symptoms (eg, heartburn), additional 4-8 week courses of omeprazole may be considered.
Maintenance of Healing of Erosive Esophagitis PRILOSEC Delayed-Release Capsules are indicated to maintain healing of erosive esophagitis. Controlled studies do not extend beyond 12 months. Pathological Hypersecretory Conditions PRILOSEC Delayed-Release Capsules are indicated for the long-term treatment of pathological hypersecretory conditions (eg, Zollinger-Ellison syndrome, multiple endocrine adenomas and systemic mastocytosis).
DOSAGE AND ADMINISTRATION
Short-Term Treatment of Active Duodenal Ulcer The recommended adult oral dose of PRILOSEC is 20 mg once daily.
Most patients heal within four weeks. Some patients may require an additional four weeks of therapy. (See INDICATIONS AND USAGE.)
H. pylori Eradication for the Reduction of the Risk of Duodenal Ulcer Recurrence
Triple Therapy (PRILOSEC/ clarithromycin/ amoxicillin) ? The recommended adult oral regimen is PRILOSEC 20 mg plus clarithromycin 500 mg plus amoxicillin 1000 mg each given twice daily for 10 days. In patients with an ulcer present at the time of initiation of therapy, an additional 18 days of PRILOSEC 20 mg once daily is recommended for ulcer healing and symptom relief.
Dual Therapy (PRILOSEC/ clarithromycin) ? The recommended adult oral regimen is PRILOSEC 40 mg once daily plus clarithromycin 500 mg t. i. d. for 14 days. In patients with an ulcer present at the time of initiation of therapy, an additional 14 days of PRILOSEC 20 mg once daily is recommended for ulcer healing and symptom relief.